Lupin receives FDA approval for Sildenafil Tablets

March 25, 2019 | Monday | News

It is a generic version of Pfizer Inc’s Viagra Tablets

Lupin has announced that it has received approval for its Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer Inc’s Viagra Tablets, 25 mg, 50 mg, and 100 mg.

Lupin’s Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg, is the generic version Pfizer Inc’s Viagra Tablets, 25 mg, 50 mg, and 100 mg. Sildenafil Tablets are a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED).

Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg had an annual sales of approximately USD 611 million in the US.